DVA geopolitical news & exposure
DVA geopolitical news and exposure. DVA appears in 202 Geopolitics Alpha notes. The newest is 21 Sep 2026, 12:08 UTC. Stored price-reaction rows cover 0 of those notes.
- US strikes on alleged drug boats could be crimes against humanity, says UN
21 Sep 2026, 12:08 UTC
- Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030
21 Sep 2026, 12:06 UTC
- How J&J paved the way for Compass’ coming psychedelic drug launch
21 Sep 2026, 11:30 UTC
- Brazil pharmaceutical distributors face mounting financial pressure
21 Sep 2026, 11:20 UTC
- FDA
21 Sep 2026, 10:26 UTC
- Xenon Stock Craters 30% on Drug Trial Setback. Its Failure Could Be This Biotech’s Gain.
21 Sep 2026, 10:03 UTC
- Are healthcare systems really ready for GLP-1s?
21 Sep 2026, 09:00 UTC
- Behind the outcomes: How whole-patient support is reshaping oncology care
21 Sep 2026, 09:00 UTC
- Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals
21 Sep 2026, 08:58 UTC
- Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
21 Sep 2026, 04:20 UTC
- Alnylam’s Zilebesiran Targets Twice-Yearly Blood Pressure Control in ZENITH Trial
20 Sep 2026, 01:01 UTC
- Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices
19 Sep 2026, 21:12 UTC
- FDA Expedited Investigational New Drug (IND) Pilot Program
18 Sep 2026, 19:55 UTC
- Generic Drugs
18 Sep 2026, 19:31 UTC
- Xenon shares fall following depression trial pause
18 Sep 2026, 15:51 UTC
- Electra amasses $350M in biotech’s latest big IPO
18 Sep 2026, 00:42 UTC
- Presidential Determination on Major Drug Transit or Major Illicit Drug Producing Countries for Fiscal Year 2027
18 Sep 2026, 00:00 UTC
- Lisata deal propels Marea’s drug pipeline to Wall Street
17 Sep 2026, 21:39 UTC
- FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
17 Sep 2026, 18:26 UTC
- North Immunology joins biotech reverse merger boom with Aethlon deal
17 Sep 2026, 15:09 UTC
- Recor Medical ex-CEO Lara Barghout joins Medtronic
16 Sep 2026, 19:52 UTC
- White House chief of staff Susie Wiles says she's cancer free
16 Sep 2026, 19:31 UTC
- TTD Expands Pharma Reach: Can New Healthcare Integrations Drive Growth
16 Sep 2026, 13:04 UTC
- FDA clears first generic radioligand drug; Sionna turns to layoffs
15 Sep 2026, 21:13 UTC
- Is Cancer the Turnaround Moderna Has Been Looking for Post-COVID?
15 Sep 2026, 16:24 UTC
- FDA launches pilot program to speed up early US drug research
15 Sep 2026, 14:00 UTC
- FDA Launches Expedited IND Pilot, Begins Accepting Applications
15 Sep 2026, 13:53 UTC
- Summit, Akeso look to shed PD-1/VEGF drug doubts with latest study results
14 Sep 2026, 20:41 UTC
- Beta Bionics’ insulin patch pump gets FDA nod
14 Sep 2026, 19:22 UTC
- AstraZeneca’s newly approved pill fails frontline breast cancer study
14 Sep 2026, 16:30 UTC
- Cellectis quits CAR-T and pivots to ‘in vivo’ gene editing
14 Sep 2026, 15:46 UTC
- Cellectis quits CAR-Ts and pivots to ‘in vivo’ gene editing
14 Sep 2026, 15:46 UTC
- GSK Presents Jideytro Data for Potential Use in First-Line NSCLC
14 Sep 2026, 15:14 UTC
- Novo Nordisk is changing its name and its culture to try to compete in the GLP-1 diet-drug wars
14 Sep 2026, 14:05 UTC
- Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars
14 Sep 2026, 13:20 UTC
- Scholar Rock SMA drug approved by FDA
14 Sep 2026, 13:00 UTC
- Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions
14 Sep 2026, 09:00 UTC
- AstraZeneca COPD Drug Cuts Exacerbations as FDA Priority Review Nears
13 Sep 2026, 10:01 UTC
- Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial Nears
12 Sep 2026, 02:01 UTC
- This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree
11 Sep 2026, 15:22 UTC